Guideline | Drug Name |
---|---|
Darzalex (daratumumab), Darzalex Faspro (daratumumab and hyaluronidase-fihj) - PA, NF | Darzalex (daratumumab), Darzalex Faspro (daratumumab and hyaluronidase-fihj) |
DAW Override | DAW override, Dispense, written |
Deferasirox products | Exjade (deferasirox), deferasirox tablet, Jadenu (deferasirox), Jadenu Sprinkle (deferasirox) |
Demser (metyrosine) | Demser (metyrosine) |
Diabetic GLP-1's | Bydureon BCise, Byetta, Rybelsus, Mounjaro, Ozempic, Trulicity, Victoza |
Diacomit (stiripentol) | Diacomit (stiripentol) |
Dibenzyline (phenoxybenzamine) | Dibenzyline (phenoxybenzamine) |
Dichlorphenamide Agents | Keveyis (dichlorphenamide), Ormalvi (dichlorphenamide) |
DPP-4 Inhibitors | Janumet (sitagliptin/metformin), Janumet XR (sitagliptin/metformin extended-release), Januvia (sitagliptin), Jentadueto (linagliptin/metformin), Jentadueto XR (linagliptin/metformin extended-release), Tradjenta (linagliptin) |
Duexis (ibuprofen and famotidine) - PA, NF | Duexis (ibuprofen/famotidine) |
Dupixent (dupilumab) | Dupixent (dupilumab) |
Elaprase (idursulfase) | Elaprase (idursulfase) [1] |
Elmiron (pentosan polysulfate sodium) | Elmiron (pentosan polysulfate sodium) |
Emflaza (deflazacort) - PA, NF | Emflaza (deflazacort) |
Enbrel (etanercept) | Enbrel (etanercept) |
Epclusa (sofosbuvir/velpatasvir) - PA, NF | Epclusa (sofosbuvir and velpatasvir) |
Epidiolex (cannabidiol) | Epidiolex (cannabidiol oral solution) |
Ergot Alkaloids | Cafergot (ergotamine tartrate and caffeine) tablet, Ergomar (ergotamine tartrate) sublingual tablet, Migergot (ergotamine tartrate and caffeine) suppository, D.H.E. 45 (dihydroergotamine mesylate) injection, Migranal (dihydroergotamine mesylate) nasal spray, Trudhesa (dihydroergotamine mesylate) nasal spray |
Erivedge (vismodegib) | Erivedge (vismodegib) |
Erythropoietic Agents - PA, NF | Aranesp (darbepoetin alfa), Epogen (epoetin alfa), Procrit (epoetin alfa), and Retacrit (epoetin alfa-epbx), Mircera (methoxy polyethylene glycol-epoetin beta) |